Clinical Trials & Research
Search Clinical Trials
Clinical Trials
New Search
Title | Study to Assess Safety and Efficacy of Atezolizumab (MPDL3280A) Compared to Best Supportive Care Following Chemotherapy in Patients With Lung Cancer [IMpower010] |
---|---|
Disease/Condition | Lung Cancer |
Description | |
Eligibility Criteria | Ages Eligible for Study: 18 Years and older (Adult, Senior) Genders Eligible for Study: Both Accepts Healthy Volunteers: No Click here for eligibility requirements |
Principal Investigator | Steven Keller, MD |
Contact Name | Alexandra Urman |
Phone | (718) 379-6868 |
Contact Email | aurman@montefiore.org |
Protocol Number | IRB# 15-06-376 |
Inclusion/Notes | This information was obtained from ClinicalTrials.gov. |
Status | Enrolling |
Adult Clinical Trial | Yes |
Pediatric Clinical Trial | No |
Adult, Pediatric, Both | Adult |